Toggle navigation
Home
Search
Services
Blog
Contact
About
Biomarker Screening with Revoluntionary Neoabs
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Angiotensins, Prostaglandins-Adrenergic Interactions
Regulation of the Mps1 Protein Kinase and Centrosome Duplication
Domestic Violence and the Parenting of Young Children
Regulation of T Lymphocyte mRNA Degradation
Hematopoietic Growth Factors, Oncogenes, and Leukemia
Recently added grants:
Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations
The role of breast stem cells in breast cancer etiology and risk prediction
Small-molecule STAT3 degraders
Interruption of squalene epoxidase and DNA damage response in cancer therapy
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N44CN73301-3-0-1
Application #
7582646
Study Section
Project Start
2007-06-01
Project End
2009-05-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N44 CA
Biomarker Screening with Revoluntionary Neoabs
/ Neoclone Biotechnology International
$206,777
NIH 2007
N01 CA
Biomarker Screening with Revolutionary Neoabs
Tucker, Ward /
$507,208
NIH 2007
N01 CA
Biomarker Screening with Revoluntionary Neoabs
/
Comments
Be the first to comment on this grant